Friday, 22 November 2013

Novo Nordisk and Roche Diabetes Care are joining forces to make insulin pump therapy simpler for people with diabetes

The the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) adopted positive opinion recommending marketing of NovoRapid® PumpCart® in Europe. NovoRapid® PumpCart® is a 1.6 ml prefilled insulin pump cartridge containing the rapid-acting insulin NovoRapid® from Novo Nordisk. It is compatible with Roche Diabetes Care’s next-generation Accu-Chek® Insight diabetes therapy system (Novo Nordisk)

Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes

This study suggests that rosiglitazone use in patients with type 2 diabetes may reduce the risk of thyroid cancer (Annals of Medicine)

Association of Helicobacter pylori infection with diabetes mellitus and diabetic nephropathy

Our meta-analyses suggest a relationship between H. pylori infection and the risk of diabetes mellitus and diabetic nephropathy. The bacterium may be able to play its pathogenic role in the whole disease process, and this action may be stronger in type 2 diabetic patients than in type 1 diabetic patients (Scandinavian Journal of Infectious Diseases)

No comments:

Post a Comment